Evidence map›Paper›PMID 41820618›Full record

ArticleThe EMBO journal2026

Serum coating enables feeder-free culture of naive human pluripotent stem cells preserving developmental potential.

Giada Rossignoli, Michael Oberhuemer, Ida Sophie Brun, Irene Zorzan, Anna Osnato, Anne Wenzel, Emiel van Genderen, Andrea Drusin, Giorgia Panebianco, Nicolò Magri and 14 more

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Giada Rossignoli *Department of Biology, University of Padua, Padua, Italy.ORCID http://orcid.org/0000-0001-6263-3549
Michael Oberhuemer *Max Perutz Labs, Vienna Biocenter Campus, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-2273-2782
Ida Sophie Brun *Novo Nordisk Foundation Center for Stem Cell Medicine - reNEW, Department of Biomedical Sciences, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0009-0003-2650-7707
Irene Zorzan *Department of Biology, University of Padua, Padua, Italy.ORCID http://orcid.org/0000-0002-9229-5293
Anna OsnatoKU Leuven-University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven, Belgium.
Anne WenzelNovo Nordisk Foundation Center for Stem Cell Medicine - reNEW, Department of Biomedical Sciences, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6187-4156
Emiel van GenderenInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
Andrea DrusinDepartment of Biology, University of Padua, Padua, Italy.
Giorgia PanebiancoDepartment of Biology, University of Padua, Padua, Italy.ORCID http://orcid.org/0009-0000-1499-3689
Nicolò MagriDepartment of Biology, University of Padua, Padua, Italy.ORCID http://orcid.org/0009-0005-7537-0588
Moritz BeckerMax Perutz Labs, Vienna Biocenter Campus, University of Vienna, Vienna, Austria.
Mairim Alexandra SolisKU Leuven-University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven, Belgium.
Chiara ColantuonoNEGEDIA S.r.l., Pozzuoli, Italy.
Sam Samuël Franciscus Allegonda van KnippenbergKU Leuven-University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven, Belgium.
Thi Xuan Ai PhamKU Leuven-University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven, Belgium.
Sherif KhodeerKU Leuven-University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven, Belgium.ORCID http://orcid.org/0000-0001-6851-8568
Paolo GrumatiTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.ORCID http://orcid.org/0000-0002-9942-9389
Davide CacchiarelliTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.ORCID http://orcid.org/0000-0002-9621-6716
Paolo MartiniDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.ORCID http://orcid.org/0000-0002-0146-1031
Nicolas RivronInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter, Vienna, Austria.
Vincent PasqueKU Leuven-University of Leuven, Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5129-0146
Jan Jakub ŻyliczNovo Nordisk Foundation Center for Stem Cell Medicine - reNEW, Department of Biomedical Sciences, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark. jan.zylicz@sund.ku.dk.ORCID http://orcid.org/0000-0001-9622-5658
Martin LeebMax Perutz Labs, Vienna Biocenter Campus, University of Vienna, Vienna, Austria. martin.leeb@univie.ac.at.ORCID http://orcid.org/0000-0001-5114-4782
Graziano MartelloDepartment of Biology, University of Padua, Padua, Italy. graziano.martello@unipd.it.ORCID http://orcid.org/0000-0001-5520-085X

Funding

Austrian Science Fund (FWF) 10.55776/I5958Austrian Science Fund (FWF) 10.55776/PAT3246524Austrian Science Fund (FWF) I5958Austrian Science Fund (FWF) P35637Danmarks Frie Forskningsfond (DFF) 0169- 00031BEC | European Research Council (ERC) 101002317EC | European Research Council (ERC) 101077271EC | European Research Council (ERC) 716910EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) 101108873EC | NextGenerationEU (NGEU) PNC 0000001 D3 4 HealthEC | NextGenerationEU (NGEU) PNRR-MR1-2022-12376821Fondazione AIRC per la ricerca sul cancro ETS (AIRC) MFAG 2020Fondazione Telethon (FT) GJC21157Fonds Wetenschappelijk Onderzoek (FWO) G0B4420NFonds Wetenschappelijk Onderzoek (FWO) G0C9320NFonds Wetenschappelijk Onderzoek (FWO) G0I7822NKU Leuven (Katholieke Universiteit Leuven) C14/21/119'la Caixa' Foundation ('la Caixa') LCF/PR/HR24/52440015Lundbeck Foundation (Lundbeckfonden) R345-2020-14979Ministero dell'Università e della Ricerca (MUR) 20224FL9T5Ministero dell'Università e della Ricerca (MUR) 2022LJZRBYMinistero dell'Università e della Ricerca (MUR) 2022RA8E3TMinistero dell'Università e della Ricerca (MUR) MCNT2 2023Ministero dell'Università e della Ricerca (MUR) P2022JLNZ7Ministero dell'Università e della Ricerca (MUR) T3-AN-09Novo Nordisk Fonden (NNF) NNF21CC0073729Signalling Molecules in Cellular Homeostasis (SMICH) 10.55776/W1261Vienna Research Group Leader VRG14-006
6 · The paper itself

Abstract

Naive human pluripotent stem cells (hPSCs) represent a pre-implantation epiblast state able to efficiently differentiate into embryonic and extraembryonic pre-implantation lineages and to self-organise in vitro into blastocyst-like structures called blastoids. Naive hPSC maintenance routinely relies on co-culture with mouse embryonic fibroblast (MEFs) as feeder cells, a method prone to variability and analytical confounders. Here, we describe a feeder-free culture system based on serum coating that supports long-term maintenance of naive hPSCs. Across five laboratories, 30 serum batches were evaluated for the expansion of eight naive hPSCs lines for up to 25 passages. Mass spectrometry analysis identified fibronectin and collagens as extracellular matrix proteins consistently present in serum coating. Cells cultured on serum coating displayed growth kinetics, clonogenic capacity, mutation rates, and global gene expression profiles comparable to MEF-based cultures. Importantly, serum-cultured naive hPSCs efficiently underwent germ layer specification, retained trophectoderm competence, and generated blastoids with efficiency similar to MEF-based cultures. Collectively, serum coating provides a scalable, cost-effective, and robust alternative to feeder-based systems, preserving genomic stability and developmental potential while eliminating MEF-associated disadvantages and variability. This platform facilitates large-scale applications of naive hPSCs and enables more reproducible mechanistic studies.

Indexed as

Cell Culture TechniquesPluripotent Stem CellsSerumAnimalsCell DifferentiationCells, CulturedCoculture TechniquesFeeder CellsFibroblastsHumansMiceBlastoidsExtracellular MatrixExtraembryonic LineagesFeeder-freeHuman Naive Pluripotent Stem Cells

Identifiers

PMID41820618
PMCPMC13083898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.